NAD+ 100 | NAD100-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Coenzyme | Half-life: IV hours, SubQ 1-2 days
Mechanism
Essential coenzyme for ATP, DNA repair, sirtuins. Declines 50% by age 50. Direct NAD+ vs precursors NMN/NR.
Dosing Protocol
Reconstitution: 100 mg/mL. 50 mg = 0.5 mL = 50 units.
Critical: More isn’t better. 50 mg EOD beats 100 mg daily. Cycle 30 days on/off.
NAD-100X | Coenzyme / NAD+ Repletion | CAS: 53-84-9
NAD+ is a critical coenzyme in cellular energy metabolism, acting as an electron carrier in mitochondrial oxidative
phosphorylation. NAD+ levels decline with age, impacting mitochondrial function, sirtuin activity (SIRT1/3), DNA repair, and
metabolic regulation. IV or SubQ NAD+ directly replenishes cellular NAD+ with rapid systemic effect. Supports energy,
cognitive function, and all NAD+-dependent enzymatic processes.
DOSING PROTOCOL
| Parameter | Details |
|---|---|
| IV Protocol | 250–1000 mg IV over 2–4 hours; weekly or monthly |
| SubQ | 25–50 mg SubQ daily (well-tolerated) |
| Reconstitution | Sterile water; use immediately |
| Cycle | Ongoing; no cycling required |
STACKING RECOMMENDATIONS
Synergistic with 5-Amino-1MQ (NNMT inhibition raises endogenous NAD+), Epithalon (SIRT1/longevity), MOTS-c
(mitochondrial NAD+ utilization), Semax/Selank (neuroprotective NAD+ demand).
NOTE: IV administration causes transient flushing, chest tightness, and nausea — slow infusion rate. SubQ is better tolerated. NMN/NR
are oral NAD+ precursors that can supplement between IV sessions.
From Collection
LEAN-15X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category:Dual GHRH Analogues + GHRP | Half-life: CJC-1295 (No DAC) ~30 min, Ipamorelin ~2 h
Mechanism
Dual GHRH analogues with a selective GHRP enhance GH pulsatility, supporting recovery, muscle repair, and lean mass.
Dosing Protocol
500 mcg–1 mg SubQ, administered 1–2 times daily; pre-sleep preferred, with post-workout dosing as a secondary option.